RxDoctor Payments Data

Ashish Shah, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Nashville, TNNPI 1154350759

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.5%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Abbott accounts for 64.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $1,600 and has fallen 73.5% since, to $424 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in TN, where the typical reported total is $4,482.

$4,159in general payments, 2019–2025

Across 22 payments — averaging $189.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Xvivo Perfusion Inc.$1K
  • Abiomed$202
  • Siemens Medical Solutions USA, Inc.$116
  • Artivion, Inc.$40
  • Medtronic$23
$819,110in research payments, 2019–2025

Across 72 payments — averaging $11,377 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$517K
  • Xvivo Perfusion Inc.$302K

What the payments were for

  • Consulting fees$52513%
  • Speaking & faculty fees$1,57538%
  • Food & beverage$2,05950%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,159 in reported general payments places this provider in the 45th percentile of 115 thoracic surgery (cardiothoracic vascular surgery) providers in Tennessee.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Tennessee

Medicare billing

Part B allowed, 2024
$274,269
Medicare patients
117
Services billed
291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium11$183
Mupirocin11$69

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →